Dual Stimuli-Responsive Nanoparticles for Controlled Release of Anticancer and Anti-inflammatory Drugs Combination-Reference-Cited by-同舟云学术

Dual Stimuli-Responsive Nanoparticles for Controlled Release of Anticancer and Anti-inflammatory Drugs Combination

Published:2017-06-19 Issue:39 Volume:23 Page:9397-9406
ISSN:0947-6539
Container-title:Chemistry - A European Journal
language:en
Short-container-title:Chem. Eur. J.

Author:

Feng Liandong¹,Wang Yuqi¹,Luo Zhiliang¹,Huang Zheng¹,Zhang Yan¹,Guo Kai²,Ye Deju¹^ORCID

Affiliation:

1. State Key Laboratory of Analytical Chemistry for Life Science; School of Chemistry and Chemical Engineering; Nanjing University; Nanjing 210023 P.R. China

2. State Key Laboratory of Materials-Oriented Chemical Engineering; College of Biotechnology and Pharmaceutical Engineering; Nanjing Tech University; Nanjing 210023 P.R. China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Publisher

Wiley

Subject

General Chemistry,Catalysis,Organic Chemistry

Reference68 articles.

1. Bioresponsive materials

2. Maßgeschneiderte Nanopartikel für den Wirkstofftransport in der Krebstherapie

3. Smart nanosystems: Bio-inspired technologies that interact with the host environment

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Folate receptor-targeted indomethacin-loaded gold nanoparticles enhance drug chemotherapeutic efficacy in glioblastoma cells and spheroids;Journal of Drug Delivery Science and Technology;2024-10

2. Innovative Solid-Phase Extraction Strategies for Improving the Advanced Chromatographic Determination of Drugs in Challenging Biological Samples;Molecules;2024-05-12

3. Stimuli responsiveness of recent biomacromolecular systems (concept to market): A review;International Journal of Biological Macromolecules;2024-03

4. Cocrystallization of multi-kinase inhibitor pazopanib with fenamic acids: improving dissolution and inhibiting cell migration;CrystEngComm;2023

5. Acidity-Activated Charge Conversion of ¹⁷⁷Lu-Labeled Nanoagent for the Enhanced Photodynamic Radionuclide Therapy of Cancer;ACS Applied Materials & Interfaces;2022-01-13